← FDA Drug Approvals (Drugs@FDA)

LITHIUM CARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2015-06-08

Drug application

FDA Application #

ANDA204445

Application type

Abbreviated New Drug Application (Generic)

Brand name

LITHIUM CARBONATE

Generic name

LITHIUM CARBONATE

Active ingredients

LITHIUM CARBONATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2015-06-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown